CN103479845B - 使用芦荟、三七制备促进雌激素分泌的冻干粉针剂的方法 - Google Patents
使用芦荟、三七制备促进雌激素分泌的冻干粉针剂的方法 Download PDFInfo
- Publication number
- CN103479845B CN103479845B CN201310448923.9A CN201310448923A CN103479845B CN 103479845 B CN103479845 B CN 103479845B CN 201310448923 A CN201310448923 A CN 201310448923A CN 103479845 B CN103479845 B CN 103479845B
- Authority
- CN
- China
- Prior art keywords
- powder
- aloe
- radix notoginseng
- freeze
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000843 powder Substances 0.000 title claims abstract description 99
- 241001116389 Aloe Species 0.000 title claims abstract description 85
- 235000011399 aloe vera Nutrition 0.000 title claims abstract description 85
- 229940011871 estrogen Drugs 0.000 title claims abstract description 23
- 239000000262 estrogen Substances 0.000 title claims abstract description 23
- 230000028327 secretion Effects 0.000 title claims abstract description 20
- 238000000034 method Methods 0.000 title claims abstract description 19
- 239000007924 injection Substances 0.000 title abstract description 28
- 238000002347 injection Methods 0.000 title abstract description 28
- 244000131316 Panax pseudoginseng Species 0.000 title abstract description 6
- 235000003181 Panax pseudoginseng Nutrition 0.000 title abstract description 6
- 230000001737 promoting effect Effects 0.000 title abstract description 5
- 238000002360 preparation method Methods 0.000 claims abstract description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000012153 distilled water Substances 0.000 claims abstract description 6
- 239000000243 solution Substances 0.000 claims abstract description 6
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 6
- 239000012528 membrane Substances 0.000 claims abstract description 5
- 239000003708 ampul Substances 0.000 claims abstract description 4
- 239000002826 coolant Substances 0.000 claims abstract description 4
- 238000001816 cooling Methods 0.000 claims abstract description 4
- 230000001954 sterilising effect Effects 0.000 claims abstract description 3
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 52
- 241000180649 Panax notoginseng Species 0.000 claims description 52
- 239000003814 drug Substances 0.000 claims description 11
- 239000000047 product Substances 0.000 claims description 11
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 6
- 238000009413 insulation Methods 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 230000002779 inactivation Effects 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 4
- 108091005804 Peptidases Proteins 0.000 claims description 3
- 239000004365 Protease Substances 0.000 claims description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 3
- 238000005352 clarification Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 230000008676 import Effects 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 11
- 238000012360 testing method Methods 0.000 abstract description 5
- 239000003098 androgen Substances 0.000 abstract description 3
- 239000003053 toxin Substances 0.000 abstract description 3
- 231100000765 toxin Toxicity 0.000 abstract description 3
- 238000004108 freeze drying Methods 0.000 abstract description 2
- 239000011259 mixed solution Substances 0.000 abstract description 2
- 238000002156 mixing Methods 0.000 abstract description 2
- 230000002040 relaxant effect Effects 0.000 abstract description 2
- 150000002632 lipids Chemical class 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 20
- 241000699666 Mus <mouse, genus> Species 0.000 description 9
- 210000002966 serum Anatomy 0.000 description 9
- 210000004291 uterus Anatomy 0.000 description 8
- 210000001672 ovary Anatomy 0.000 description 7
- 239000000463 material Substances 0.000 description 6
- RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 230000002146 bilateral effect Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 210000001541 thymus gland Anatomy 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 102000009151 Luteinizing Hormone Human genes 0.000 description 2
- 108010073521 Luteinizing Hormone Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000011121 vaginal smear Methods 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 101100382236 Mus musculus Cacnb4 gene Proteins 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000001315 anti-hyperlipaemic effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 229960000452 diethylstilbestrol Drugs 0.000 description 1
- 229940085071 diethylstilbestrol 1 mg Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000009806 oophorectomy Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000013324 preserved food Nutrition 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
组别 | 剂量mg/kg | 胸腺指数(mg/10g) | 脾脏指数(mg/10g) | 子宫指数(mg/10g) |
正常组 | -- | 28.61±8.31 | 55.27±4.20 | 41.35±8.71 |
模型组 | -- | 30.90±8.21 | 88.10±1.94 | 28.72±7.99$$ |
己烯雌酚 | 1mg/kg | 32.99±8.11 | 66.67±16.93 | 62.67±11.89** |
J01低剂量 | 144 | 26.60±12.71 | 117.33±33.84 | 45.98±11.87** |
J01高剂量 | 288 | 27.16±11.90 | 136.44±21.54 | 46.04±16.41** |
J02低剂量 | 180 | 31.69±9.04 | 96.17±15.61 | 30.26±9.40 |
J02高剂量 | 360 | 23.75±10.24 | 109.28±35.03 | 45.17±24.02* |
组别 | 剂量mg/kg | E2 (雌激素)(pg/ml) |
正常组 | -- | 126.35±30.62 |
模型组 | -- | 61.18±18.76$$ |
己烯雌酚组 | 1mg/kg | 113.81±33.85 |
J01低剂量 | 144 | 85.66±27.39* |
J01高剂量 | 288 | 96.05±24.91** |
J02低剂量 | 180 | 72.12±20.61 |
J02高剂量 | 360 | 80.82±23.56 |
组别 | 剂量mg/kg | LH (促黄体生成素) (ng/ml) |
正常组 | -- | 13.27±4.8 |
模型组 | -- | 52.58±5.77$$ |
己烯雌酚组 | 1mg/kg | 31.33±4.51 |
J01低剂量 | 144 | 42.62±5.13* |
J01高剂量 | 288 | 37.71±6.22* |
J02低剂量 | 180 | 46.39±7.45 |
J02高剂量 | 360 | 47.87±7.04 |
组别 | 剂量mg/kg | FSH(卵泡刺激素)(ng/ml) |
正常组 | -- | 4.81±1.35 |
模型组 | -- | 32.23±5.35$$ |
己烯雌酚组 | 1mg/kg | 22.54±6.97 |
J01低剂量 | 144 | 30.15±8.83 |
J01高剂量 | 288 | 25.94±7.41 |
J02低剂量 | 180 | 33.17±10.02 |
J02高剂量 | 360 | 31.39±9.77 |
Claims (5)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310448923.9A CN103479845B (zh) | 2013-09-28 | 2013-09-28 | 使用芦荟、三七制备促进雌激素分泌的冻干粉针剂的方法 |
PCT/CN2013/001297 WO2015042757A1 (zh) | 2013-09-28 | 2013-10-28 | 使用芦荟、三七制备促进雌激素分泌的冻干粉针剂的方法 |
HK14103920.3A HK1190634A1 (zh) | 2013-09-28 | 2014-04-23 | 使用蘆薈、三七製備促進雌激素分泌的凍乾粉針劑的方法 |
US15/011,450 US10016366B2 (en) | 2013-09-28 | 2016-01-29 | Method of preparing lyophilized powder for injection comprising aloe and Panax pseudo-ginseng |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310448923.9A CN103479845B (zh) | 2013-09-28 | 2013-09-28 | 使用芦荟、三七制备促进雌激素分泌的冻干粉针剂的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103479845A CN103479845A (zh) | 2014-01-01 |
CN103479845B true CN103479845B (zh) | 2015-04-15 |
Family
ID=49820658
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310448923.9A Expired - Fee Related CN103479845B (zh) | 2013-09-28 | 2013-09-28 | 使用芦荟、三七制备促进雌激素分泌的冻干粉针剂的方法 |
Country Status (4)
Country | Link |
---|---|
US (1) | US10016366B2 (zh) |
CN (1) | CN103479845B (zh) |
HK (1) | HK1190634A1 (zh) |
WO (1) | WO2015042757A1 (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1349799A (zh) * | 2000-10-19 | 2002-05-22 | 王伦桥 | 中药汉荟合成剂 |
CN101697951A (zh) * | 2009-10-28 | 2010-04-28 | 翁民辉 | 一种用于便后清洁的防护液及使用方法 |
CN101948550A (zh) * | 2010-10-13 | 2011-01-19 | 云南万绿生物股份有限公司 | 高纯度芦荟乙酰化多糖的加工方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1657073A (zh) * | 2004-02-16 | 2005-08-24 | 邱芳龙 | 一种预防妇女更年期综合症提高其青春活力的保健品 |
CN102090451A (zh) * | 2009-12-10 | 2011-06-15 | 吴风英 | 一种三七芦荟奶茶 |
CN102309667A (zh) * | 2011-09-22 | 2012-01-11 | 西安理工大学 | 一种用于治疗烫伤的药膏及其制备方法 |
-
2013
- 2013-09-28 CN CN201310448923.9A patent/CN103479845B/zh not_active Expired - Fee Related
- 2013-10-28 WO PCT/CN2013/001297 patent/WO2015042757A1/zh active Application Filing
-
2014
- 2014-04-23 HK HK14103920.3A patent/HK1190634A1/zh not_active IP Right Cessation
-
2016
- 2016-01-29 US US15/011,450 patent/US10016366B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1349799A (zh) * | 2000-10-19 | 2002-05-22 | 王伦桥 | 中药汉荟合成剂 |
CN101697951A (zh) * | 2009-10-28 | 2010-04-28 | 翁民辉 | 一种用于便后清洁的防护液及使用方法 |
CN101948550A (zh) * | 2010-10-13 | 2011-01-19 | 云南万绿生物股份有限公司 | 高纯度芦荟乙酰化多糖的加工方法 |
Non-Patent Citations (2)
Title |
---|
三七芦荟混合物调节动物血糖血脂作用研究;贺小琼等;《云南中医中药杂志》;20040420;第25卷(第02期);40-42 * |
含雌激素中药脑保护作用的实验研究;张博生等;《中国临床康复》;20041205;第8卷(第34期);7740-7741 * |
Also Published As
Publication number | Publication date |
---|---|
US20160143853A1 (en) | 2016-05-26 |
US10016366B2 (en) | 2018-07-10 |
WO2015042757A1 (zh) | 2015-04-02 |
HK1190634A1 (zh) | 2014-07-11 |
CN103479845A (zh) | 2014-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101648002B (zh) | 一种用于治疗皮肤破损溃疡的药物组合物及其应用 | |
CN105596705A (zh) | 一种中药组合物在制备治疗脑血栓的药物中的用途 | |
CN102988899B (zh) | 一种治疗乳汁不通的中药组合物 | |
CN107875370B (zh) | 用于促进肠蠕动排气防止肠粘连的中药组合物及制备方法 | |
CN103479845B (zh) | 使用芦荟、三七制备促进雌激素分泌的冻干粉针剂的方法 | |
CN105616992A (zh) | 一种用于麻醉止痛的药物及制备方法 | |
CN105412867A (zh) | 一种用于妇产科术后的中西药物及其制备方法 | |
CN108434227A (zh) | 一种治疗脚气的药物 | |
CN103705760B (zh) | 一种用于产后会阴疼痛的栓剂制备方法 | |
CN105125639A (zh) | 一种防治奶牛乳房炎的中药组合物 | |
CN105412621A (zh) | 一种制备治疗痔疮的药物组合物的方法 | |
CN110742923A (zh) | 一种治疗产妇拘乳的中药组合物、中药制剂及其制备方法 | |
CN103494978B (zh) | 使用芦荟、灵芝制备治疗肝腹水瘤的冻干粉针剂的方法 | |
CN100482268C (zh) | 一种治疗高血压病的药物组合物及其茶剂制备方法 | |
CN104758358A (zh) | 一种用于湿疹的药物组合物及其制备方法 | |
CN104524320A (zh) | 一种茶花烫伤药 | |
CN104689296A (zh) | 乌风蛇油产品及其制备方法 | |
CN103705696A (zh) | 使用芦荟、山药制备治疗糖尿病注射液粉针剂的方法 | |
CN103238834A (zh) | 一种治疗皮肤瘙痒的组合物及其制备方法 | |
CN103505593B (zh) | 一种去腐生肌的中草药制剂 | |
CN107811907A (zh) | 一种促进皮下脂肪分解的身体乳 | |
CN105288016B (zh) | 一种防治膝骨关节炎外用中药乳剂及其制备方法 | |
CN106389702A (zh) | 一种用于恢复妇产科手术病症的中药及其制备方法 | |
CN104116771B (zh) | 一种具有活血止痛作用的红药片及其制备方法 | |
CN105497866A (zh) | 一种治疗青光眼的中药组合物及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1190634 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: KAIFENG JIUFULAI BIOLOGY TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: HENAN JUFEEL SCIENCE + TECHNOLOGY GROUP CO., LTD. Effective date: 20150512 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 450000 ZHENGZHOU, HENAN PROVINCE TO: 475000 KAIFENG, HENAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150512 Address after: 475000 government office of Xinghua Road, Xinghua Road, Xinghua Town, Kaifeng City, Henan Province Patentee after: KAIFENG JUFEEL BIOLOGICAL TECHNOLOGY CO.,LTD. Address before: 450000, No. 21, building 2, No. 2106, East 16, agricultural road, Jinshui District, Henan, Zhengzhou Patentee before: Henan Jiufulai Technology Group Co.,Ltd. |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1190634 Country of ref document: HK |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150415 |
|
CF01 | Termination of patent right due to non-payment of annual fee |